Related references
Note: Only part of the references are listed.Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
Yi-Wen Huang et al.
ANTIVIRAL THERAPY (2010)
The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease
Stewart Leung et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
Interleukin-17-Producing CD4(+) T Cells Increase with Severity of Liver Damage in Patients with Chronic Hepatitis B
Ji-Yuan Zhang et al.
HEPATOLOGY (2010)
Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B
Yoshiyasu Karino et al.
HEPATOLOGY INTERNATIONAL (2010)
Long-term use of entecavir in nucleoside-naive Japanese patients with chronic hepatitis B infection
Osamu Yokosuka et al.
JOURNAL OF HEPATOLOGY (2010)
Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties
Eva Billerbeck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir
Won Hyeok Choe et al.
ANTIVIRAL THERAPY (2009)
The Interleukin-17 Pathway Is Involved in Human Alcoholic Liver Disease
Arnaud Lemmers et al.
HEPATOLOGY (2009)
Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus
Fu-Sheng Wang et al.
Expert Review of Gastroenterology & Hepatology (2009)
OPINION Interplay between the T(H)17 and T-Reg cell lineages: a (co-)evolutionary perspective
Casey T. Weaver et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Programmed death-1 up-regulation is involved in the attrition of cytomegalovirus-specific CD8+ T cells in acute self-limited hepatitis B virus infection
Ji-Yuan Zhang et al.
JOURNAL OF IMMUNOLOGY (2008)
Hepatitis C virus-specific th17 cells are suppressed by virus-induced TGF-β
Aileen G. Rowan et al.
JOURNAL OF IMMUNOLOGY (2008)
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Liang Zhou et al.
NATURE (2008)
Drug therapy - Hepatitis B virus infection
Jules L. Dienstag
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Interplay between pathogenic Th17 and regulatory T cells
Mohamed Oukka
ANNALS OF THE RHEUMATIC DISEASES (2007)
Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challenges
Fu-Sheng Wang
HEPATOLOGY RESEARCH (2007)
Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B
Jeroen N. Stoop et al.
VIROLOGY (2007)
Interleukin-17 as a new marker of severity of acute hepatic injury
Yuki Yasumi et al.
HEPATOLOGY RESEARCH (2007)
Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B1
Dongping Xu et al.
JOURNAL OF IMMUNOLOGY (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
M Veldhoen et al.
IMMUNITY (2006)
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection
JN Stoop et al.
HEPATOLOGY (2005)
Immunology of hepatitis B virus and hepatitis C virus infection
B Rehermann et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection
O Franzese et al.
JOURNAL OF VIROLOGY (2005)
Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses
S Sakaguchi
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B
C Boni et al.
JOURNAL OF HEPATOLOGY (2003)
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy
C Boni et al.
HEPATOLOGY (2001)
Share Paper
